Metraipolis › archive › dc_322fcbc8debc

Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention — Europe PMC PMID:41830038

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41830038
DOI
10.3390/nu18050868
License (as archived)
solo-consultazione
Archived
2026-11-04T23:59:44.851Z
SHA-256 of the archived text
1ffabc6df4d5d87d2dc48559336f88b4e338f1f4eb7364d250736f5c3b75d4c5
Stable URL of this page
https://metraipolis.com/documento/dc_322fcbc8debc

How to cite

Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention — Europe PMC PMID:41830038 — Europe PMC (en), https://europepmc.org/article/MED/41830038 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_322fcbc8debc (Metraipolis archive dc_322fcbc8debc, sha256 1ffabc6df4d5d87d2dc48559336f88b4e338f1f4eb7364d250736f5c3b75d4c5)
BibTeX
@misc{dc322fcbc8debc,
  title = {Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention — Europe PMC PMID:41830038},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41830038},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_322fcbc8debc; sha256 1ffabc6df4d5d87d2dc48559336f88b4e338f1f4eb7364d250736f5c3b75d4c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41830038. Agents can read the archived copy with the MCP tool read_document.